Jin Y J, Burakoff S J, Bierer B E
Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
J Biol Chem. 1992 Jun 5;267(16):10942-5.
Two FK506 binding proteins of molecular mass 12 kDa (FKBP12) and 13 kDa (FKBP13) have been identified as common cellular receptors of the immunosuppressants FK506 and rapamycin. Here we report the molecular cloning and overexpression of a 25-kDa rapamycin and FK506 binding protein (termed FKBP25) with peptidylprolyl cis-trans-isomerase (PPIase) activity. The amino acid sequence, predicted from the FKBP25 cDNA, shares identity with FKBP12 (44%) and FKBP13 (47%) in the C-terminal 97 amino acids. Unlike either FKBP12 or FKBP13, the nucleotide sequence of FKBP25 contains a number of putative nuclear localization sequences. The PPIase activity of recombinant FKBP25 was comparable with that of FKBP12. The PPIase activity of FKBP25 was far more sensitive to inhibition by rapamycin (IC50 = 50 nM) than FK506 (IC50 = 400 nM). PPIase activity of 100 nM FKBP25 was almost completely inhibited by 150 nM rapamycin while only 90% inhibition was achieved by 4 microM FK506. These data demonstrate that FKBP25 has a higher affinity for rapamycin than for FK506 and suggest that this cellular receptor may be an important target molecule for immunosuppression by rapamycin.
分子量为12 kDa的两种FK506结合蛋白(FKBP12)和13 kDa的(FKBP13)已被鉴定为免疫抑制剂FK506和雷帕霉素的常见细胞受体。在此,我们报告一种具有肽基脯氨酰顺反异构酶(PPIase)活性的25 kDa雷帕霉素和FK506结合蛋白(称为FKBP25)的分子克隆及过表达。从FKBP25 cDNA预测的氨基酸序列在C端97个氨基酸中与FKBP12(44%)和FKBP13(47%)具有同源性。与FKBP12或FKBP13不同,FKBP25的核苷酸序列包含一些推定的核定位序列。重组FKBP25的PPIase活性与FKBP12相当。FKBP25的PPIase活性对雷帕霉素抑制(IC50 = 50 nM)的敏感性远高于FK506(IC50 = 400 nM)。150 nM雷帕霉素几乎完全抑制了100 nM FKBP25的PPIase活性,而4 μM FK506仅实现了90%的抑制。这些数据表明FKBP25对雷帕霉素的亲和力高于对FK506的亲和力,并提示这种细胞受体可能是雷帕霉素免疫抑制作用的重要靶分子。